Hyperlipidemia-induced metabolic changes in regulatory T cells result in altered function.

Area of Science:

• Immunology
• Metabolic Research
• Cellular Biology

Background:

• Regulatory T cells (Tregs) are crucial for immune homeostasis and preventing autoimmunity.
• The impact of hyperlipidemia on Treg function and the underlying mechanisms remain largely undefined.
• Previous work indicated hyperlipidemia alters Treg function, reducing their efficacy.

Purpose of the Study:

• To elucidate the mechanisms by which hyperlipidemia affects Treg function.
• To investigate the role of cellular metabolism and specific signaling pathways in hyperlipidemia-induced Treg alterations.

Main Methods:

• Live-cell metabolic assays were employed to assess Treg metabolism in hyperlipidemic mouse models.
• The role of the serine/threonine kinase Akt2 (PKB-β) was investigated using genetic manipulation (Akt2 knockout and constitutively active Akt2 expression).
• Flow cytometry and cytokine analysis were used to evaluate Treg subsets and inflammatory profiles.

Main Results:

• Hyperlipidemia significantly increased Treg metabolism, but not that of conventional T cells.
• This metabolic increase was dependent on the activation of Akt2, a key signaling molecule.
• Akt2 activation in Tregs led to increased glycolysis, altered Treg subsets, and promoted the production of inflammatory cytokines.

Conclusions:

• Hyperlipidemia disrupts Treg function by enhancing their metabolism through Akt2 activation.
• This Akt2-mediated metabolic reprogramming contributes to Treg plasticity and diminished immune suppressive capacity.
• Findings highlight a critical link between metabolic dysregulation and immune dysfunction in hyperlipidemic conditions.